---
schema_version: "secwatch.filing_event.v1"
accession: "0000950159-23-000157"
form_type: "8-K"
ticker: "CI"
cik: "0001739940"
company_name: "Cigna Group"
filed_at: "2023-05-01T23:59:59+00:00"
generated_at: "2026-06-16T05:10:22.073360+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Cigna appoints Dr. Philip Ozuah to Board of Directors effective June 1, 2023

## Summary
- Dr. Philip Ozuah appointed independent director on Cigna Board effective June 1, 2023.
- Ozuah is President & CEO of Montefiore Medicine, overseeing 13 hospitals and 300 ambulatory sites.
- He brings deep expertise in value-based care and population health from 32 years at Montefiore.
- Over 60% of Cigna's Board has been refreshed in the past five years to enhance diversity.
- Ozuah will serve on the People Resources and Compliance Committees.

## SEC filing metadata
- accession: 0000950159-23-000157
- form_type: 8-K
- ticker: CI
- cik: 0001739940
- company_name: Cigna Group
- filed_at: 2023-05-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739940/000095015923000157/0000950159-23-000157-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739940/000095015923000157/cigna8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950159-23-000157
- JSON: https://secwatch.observer/filing/0000950159-23-000157.json
- Plain text: https://secwatch.observer/filing/0000950159-23-000157.txt

## Key facts
- Executive change
  Dr. Philip Ozuah was appointed as Director at Cigna Group.
  - Action: appointed
  - Role: Director
  source text: On April 26, 2023, the board of directors (the “Board”) of The Cigna Group (the “Company” or “our”) appointed Dr. Philip Ozuah as an independent member of our Board and to the People Resources and Compliance Committees, which appointments are effective June 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739940/000095015923000157/0000950159-23-000157-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
